KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Cash (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Change in Cash for 16 consecutive years, with -$630.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Change in Cash fell 132.66% year-over-year to -$630.0 million, compared with a TTM value of -$4.1 billion through Dec 2024, down 822.05%, and an annual FY2025 reading of $5.8 billion, up 243.92% over the prior year.
  • Change in Cash was -$630.0 million for Q4 2024 at Thermo Fisher Scientific, up from -$2.4 billion in the prior quarter.
  • Across five years, Change in Cash topped out at $5.6 billion in Q4 2022 and bottomed at -$7.6 billion in Q4 2021.
  • Average Change in Cash over 5 years is $80.9 million, with a median of $808.5 million recorded in 2020.
  • The sharpest move saw Change in Cash crashed 904.93% in 2021, then surged 554.76% in 2024.
  • Year by year, Change in Cash stood at $2.8 billion in 2020, then tumbled by 373.21% to -$7.6 billion in 2021, then skyrocketed by 174.14% to $5.6 billion in 2022, then crashed by 65.57% to $1.9 billion in 2023, then tumbled by 132.66% to -$630.0 million in 2024.
  • Business Quant data shows Change in Cash for TMO at -$630.0 million in Q4 2024, -$2.4 billion in Q3 2024, and $1.6 billion in Q2 2024.